Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer

Journal of the American College of Surgeons

Volumn 197, Issue 4, 2003, Pages 565-574

  Bristow, Robert E ^a   Del Carmen, Marcela G ^a   Kaufman, Howard S ^a,b   Montz, Fredrick J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BYPASS SURGERY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLORECTAL ANASTOMOSIS; COLOSTOMY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE DIVERSION; MINIMAL RESIDUAL DISEASE; OPERATION DURATION; OVARIECTOMY; OVARY CANCER; PELVIC DISEASE; PRIORITY JOURNAL; REOPERATION; SURGICAL STAPLING; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 1242284218     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(03)00478-2     Document Type: Article

References (37)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics 2002. CA Cancer J Clin. 52:2002;23-47.
2. FIGO stages - 1988 revision. Gynecol Oncol. 35:1989;125-127.
3. Hoskins W.J., Bundy B.N., Thigpen J.T., Omura G.A. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer a Gynecologic Oncology Group study . Gynecol Oncol. 47:1992;159-166.
4. Marsden D.E., Friedlander M., Hacker N.F. Current management of epithelial ovarian carcinoma a review . Semin Surg Oncol. 19:2000;11-19.
5. Hudson C.N. A radical operation for fixed ovarian tumors. J Obstet Gynaecol Br Cwlth. 75:1968;1155-1160.
6. Hudson C.N., Chir M. Surgical treatment of ovarian cancer. Gynecol Oncol. 1:1973;370-378.
7. st ed. 1996;Churchill Livingstone, Inc, New York. 451-568.
8. Sugarbaker P.H. Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. Cancer Treat Res. 81:1996;75-87.
9. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-480.
10. Hacker N.F., Berek J.S., Lagasse L.D., et al. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol. 61:1983;413-420.
11. Heintz A.P.M., Hacker N.F., Berek J.S., et al. Cytoreductive surgery in ovarian carcinoma feasibility and morbidity . Obstet Gynecol. 67:1986;783-788.
12. Piver M.S., Baker T. The potential for optimal (≤2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center a prospective study . Gynecol Oncol. 24:1986;1-8.
13. Piver M.S., Lele S.B., Marchetti D.L., et al. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol. 6:1988;983-989.
14. Bertelson K. Tumor reduction surgery and long-term survival in advanced ovarian cancer a DACOVA study . Gynecol Oncol. 38:1990;203-209.
15. Eisenkop S.M., Spirtos N.M., Montag T.W., et al. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 47:1992;203-209.
16. Guidozzi F., Ball J.H. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 53:1994;326-330.
17. Eisenkop S.M., Friedman R.L., Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer a prospective study . Gynecol Oncol. 69:1998;103-108.
18. Chi D.S., Liao J.B., Leon L.F., et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol. 82:2001;532-537.
19. Dauplat J., LeBouëdec G., Pomel C., Scherer C. Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol. 19:2000;42-48.
20. Clayton R.D., Obemair A., Hammond I.G., et al. The western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol. 84:2002;53-57.
21. Scarabelli C., Gallo A., Franceschi S., et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer. 88:2000;389-397.
22. Devi K.U., Banfa U.D., Ahuja V., Ramesh C. Induction chemotherapy and interval debulking surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 12:2002;521. (Abstract #OV8).
23. Webb M.J. Cytoreduction in ovarian cancer achievability and results . Baillieres Clin Obstet Gynaecol. 3:1989;83-94.
24. Makar A.P., Baekelandt M., Tropé C.G., Kristensen G.B. The prognostic significance of residual disease, FIGO substage, tumor histology and grade in patients with FIGO Stage III ovarian cancer. Gynecol Oncol. 56:1995;175-180.
25. Benedetti-Panici P., Maneschi F., Scambia G., et al. The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma. Obstet Gynecol. 87:1996;532-538.
26. Barber H.R.K., Brunschwig A. Pelvic exenteration for locally advanced and recurrent ovarian cancer. Surgery. 58:1965;935-937.
27. Sonnendecker E.W.W., Beale P.G. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg. 74:1989;10-12.
28. Berek J.S., Hacker N.F., Lagasse L.D. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol. 64:1984;715-720.
29. Soper J.T., Couchman G., Berchuk A., Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol. 41:1991;239-244.
30. Obermair A., Hagenauer S., Tamandl D., et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol. 83:2001;115-120.
31. Bridges J.E., Leung Y., Hammond I.G., McCartney A.J. En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy the KEMH experience . Int J Gynecol Cancer. 3:1993;199-202.
32. Barnes W., Johnson J., Waggoner S., et al. Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors. Gynecol Oncol. 42:1991;151-155.
33. Sainz de la Cuesta R., Goodman A., Halverson S.S., Fuller A.F. En bloc pelvic peritoneal resection of the intraperitoneal pelvic viscera in patients with advanced epithelial ovarian cancer. Cancer J Sci Am. 2:1996;152-157.
34. Eisenkop S.M., Nalick R.H., Teng N.N.H. Modified posterior exenteration for ovarian cancer. Obstet Gynecol. 78:1991;879-885.
35. Hertel H., Diebolder H., Herrmann J., et al. Is the decision for colorectal resection justified by histopathologic findings a prospective study of 100 patients with advanced ovarian cancer . Gynecol Oncol. 83:2001;481-484.
36. Spirtos N.M., Eisenkop S.M., Schlaerth J.B., Ballon S.C. Second-look laparotomy after modified posterior exenteration patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer . Am J Obstet Gynecol. 182:2000;1321-1327.
37. Tamussino K.F., Lim P.C., Webb M.J., et al. Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol. 80:2001;79-84.